We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
An advisory panel of the FDA has judged that US tobacco firm PMI has not been able to prove that its new iQOS electronic tobacco device can reduce the risk of smoking-related diseases, and thus should not be able to make such a claim.